Panic attack like episodes possibly associated with pramipexole therapy in Parkinson's disease.
Alonso-Navarro
H
H
Jiménez-Jiménez
F J
FJ
D001008:Anxiety Disorders / Q000139:chemically induced / Q000503:physiopathology; D052160:Benzothiazoles / Q000008:administration & dosage / Q000009:adverse effects*; D002230:Carbidopa / Q000627:therapeutic use; D002490:Central Nervous System / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D003975:Diazepam / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000008:administration & dosage / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D018755:GABA Agonists / Q000627:therapeutic use; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008875:Middle Aged; D016584:Panic Disorder / Q000139:chemically induced* / Q000503:physiopathology; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy*; D000077487:Pramipexole; D012646:Self Administration
D052160:Benzothiazoles; D018491:Dopamine Agonists; D018755:GABA Agonists; D007980:Levodopa; D000077487:Pramipexole; D002230:Carbidopa; D003975:Diazepam